Fig. 4

Outcomes of patients according to the development of cancer after renal biopsy. a) and d) ESRD free-survival rate, b) and e) Death-free survival rate, and c and f) Composite event of death- or ESRD-free survival rate. a), b), and c) in all patients and d), e), and f) in patients with membranous nephropathy. P-values were calculated by the log-rank test